麻豆传媒

The selected newsroom has been added to your list of favorites. Go to My Favorites
Boston, MA USA

Our 麻豆传媒 on 麻豆传媒
View All >

麻豆传媒: 67e407879094d_DanaFarberBuilding.jpg

FDA Approves Dual-Action Drug for Patients with Previously Treated Advanced Neuroendocrine Tumors, Backed by Dana-Farber Research

The FDA approval was based on results from the CABINET study, a phase 3 pivotal trial evaluating cabozantinib compared with placebo in two groups of patients with previously treated NETs: advanced pancreatic NETs and advanced extra-pancreatic NETs....
26-Mar-2025 10:15 AM EDT Add to Favorites

Potential Targeted Therapy for Pediatric Brain Cancer Identified by Dana-Farber Team

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever clinical test of the targeted therapy avapritinib in pediatric and young patients with a form of high-grade...
20-Mar-2025 9:00 AM EDT Add to Favorites

Kimberly Stegmaier named as Pediatric Oncology Chair at Dana-Farber

Kimberly Stegmaier, MD, was named Chair of Pediatric Oncology at Dana-Farber Cancer Institute and Associate Chief of the Division of Hematology/Oncology at Boston Children鈥檚 Hospital, in an announcement made today. Her appointment is effective...
19-Feb-2025 2:00 PM EST Add to Favorites

EMBARGOED: Study Reveals Activity of Navtemadlin in Glioblastoma, Points to Possible Treatment Improvements

Clinical research by Dana-Farber scientists suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could increase efficacy. Navtemadlin is an MDM2 inhibitor...
19-Feb-2025 9:00 AM EST Add to Favorites

Dana-Farber Researchers to Present Key Transplant and Cellular Therapy Studies at 2025 Tandem Meetings

Dana-Farber Cancer Institute researchers will present key research studies at the 2025 Tandem Meetings, the premier conference in hematopoietic cell transplantation (HCT) and cellular therapy.
12-Feb-2025 8:10 PM EST Add to Favorites

麻豆传媒: 67ab739b28b14_YawkeyEvening.jpg

Dana-Farber Researchers Present Findings at 2025 ASCO Genitourinary Cancers Symposium

Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) Cancers Symposium, on February 13-15, 2025. The Dana-Farber led research exemplifies innovative and multidisciplinary expertise...
11-Feb-2025 7:55 PM EST Add to Favorites

麻豆传媒: 67a241740cd7c_DanaFarberBuilding.jpg

Cancer Vaccine Shows Promise for Patients with Stage III and IV Kidney Cancer

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after...
5-Feb-2025 11:30 AM EST Add to Favorites

麻豆传媒: 679a768586b33_BradleyBernsteinSOG1200.jpg

AI Model Learns Generalized 鈥淟anguage鈥� of Regulatory Genomics, Predicts Cellular Stories

A team of investigators from Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, Google, and Columbia University have created an artificial intelligence model that can predict which genes are expressed in any type of human cell.
29-Jan-2025 7:20 PM EST Add to Favorites


See All News

Our Experts on News

Movie release prompts national conversation about colorectal cancer in the Black community

Marvel Studios鈥� movie, 鈥淏lack Panther: Wakanda Forever,鈥� is the highly anticipated sequel to 鈥淏lack Panther,鈥� hitting theaters on November 11th. It will premiere without 鈥淏lack Panther鈥� star Chadwick Boseman, who passed away in 2020...
8-Nov-2022 3:05 PM EST

麻豆传媒: Yawkey Building 2.jpg

Dana-Farber to hold a discussion for cancer patients and survivors about the Covid-19 vaccine

Dana-Farber Cancer Institute is having a virtual discussion for cancer patients and survivors about the Covid-19 vaccine on January 27, 2020 at 5 pm.
25-Jan-2021 12:05 PM EST

麻豆传媒: Dr.JeffreyMeyerhardtFINAL.jpg

Colorectal Cancer: Five Things You Need To Know

With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST

麻豆传媒: AnnPartridge.jpg

Leading Breast Cancer Expert Available to Comment on Young Women with Breast Cancer

11-Nov-2013 5:00 PM EST

麻豆传媒: PF_SOG_7837.jpg

National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support

17-Sep-2013 3:00 PM EDT

麻豆传媒: Dr.Haddadphoto.jpg

Vaccinating Children Against HPV?

The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT

麻豆传媒: Andrea_Patenaude.jpg

Prophylactic Double Mastectomy: Angelina Makes a Private Choice a Public Issue

24-May-2013 3:00 PM EDT

麻豆传媒: Carlos_Rodriguez-Galindo_SOG_6619_09.jpg

News Tip: New Research on Teenage Girls and Melanoma Makes This the Season for Tanning Stories

Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT

See All Experts

Our YouTube Videos
View All >

About

The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.

Experts

Twitter

Facebook

close
0.41872